🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Lee J. Helman

American Osteopathic Association

ORCID: 0000-0001-9553-4475
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma”.

SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma

Cancer(2020)10.1002/cncr.33349
N/A
1.4DataRank · unranked
47 citations

Karla V. Ballman, Lee J. Helman, Shreyaskumar Patel, Jeremy Whelan, Brigitte C. Widemann +9 more

A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-2168
N/A
0.815DataRank · unranked
22 citations

R. Taylor Sundby, Mary Frances Wedekind, Fernanda I. Arnaldez, Jaydira Del Rivero, Lori Wiener +27 more

Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0709
N/A
0.652DataRank · unranked
20 citations

R. Taylor Sundby, Donna Bernstein, John Glod, Rosandra N. Kaplan, Marielle E. Yohe +17 more

CDK9 Blockade Exploits Context-dependent Transcriptional Changes to Improve Activity and Limit Toxicity of Mithramycin for Ewing Sarcoma

Molecular Cancer Therapeutics(2020)10.1158/1535-7163.mct-19-0775
N/A
0.500DataRank · unranked
27 citations

Joel H. Everett, Elissa A. Boguslawski, Brandon M. Oswald, Zachary Madaj, Ian Beddows +9 more

Supplemental Methods from Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma

(2023)10.1158/0008-5472.22422704
N/A
0DataRank · unranked
0 citations

Anna E. Gibson, Sameer H. Issaq, Nobu Oshima, Joshua T. Baumgart, Leah D. Edessa +23 more

Data from A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas

(2023)10.1158/1078-0432.c.6516826.v1
N/A
0DataRank · unranked
0 citations

Eunice H. Rhee, Elizabeth J. Read, Hanh Khuu, Susan F. Leitman, Donna Bernstein +9 more

Supplemental Methods from Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma

Figshare(2023)10.1158/0008-5472.22422704.v1
N/A
0DataRank · unranked
0 citations

Anna E. Gibson, Sameer H. Issaq, Nobu Oshima, Joshua T. Baumgart, Leah D. Edessa +23 more

LRRC15 antibody‐drug conjugates show promise as osteosarcoma therapeutics in preclinical studies

Pediatric Blood & Cancer(2020)10.1002/pbc.28771
N/A
0DataRank · unranked
24 citations

Sanjit Mukherjee, Paul S. Meltzer, James W. Purcell, Lee J. Helman, Katherine K. Slemmons

Recent Advances in Pediatric Cancer Research

Cancer Research(2021)10.1158/0008-5472.can-21-1191
N/A
0DataRank · unranked
24 citations

Lee J. Helman, Troy A. McEachron

Results of a phase I trial of ganitumab plus dasatinib in patients with rhabdomyosarcoma (RMS).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11561
N/A
0DataRank · unranked
4 citations

Donna Bernstein, John Glod, Rosandra N. Kaplan, John Shern, Marielle E. Yohe +14 more